Display options
Cite
Vaidya A, Vaidya P, Both B, et al. Cost Effectiveness Analysis of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in Early Breast Cancer Patients. Value Health. 2014;17(7):A640doi: 10.1016/j.jval.2014.08.2306.
Vaidya, A., Vaidya, P., Both, B., Brew-Graves, C., & Vaidya, J. (2014). Cost Effectiveness Analysis of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in Early Breast Cancer Patients. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A640. https://doi.org/10.1016/j.jval.2014.08.2306
Vaidya, A, et al. "Cost Effectiveness Analysis of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in Early Breast Cancer Patients." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A640. doi: https://doi.org/10.1016/j.jval.2014.08.2306
Vaidya A, Vaidya P, Both B, Brew-Graves C, Vaidya J. Cost Effectiveness Analysis of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in Early Breast Cancer Patients. Value Health. 2014 Nov;17(7):A640. doi: 10.1016/j.jval.2014.08.2306. Epub 2014 Oct 26. PMID: 27202288.
Copy Download .nbib Format: NLM
Share it on

Value Health. 2014 Nov;17(7):A640. doi: 10.1016/j.jval.2014.08.2306. Epub 2014 Oct 26.

Cost Effectiveness Analysis of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in Early Breast Cancer Patients.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

A Vaidya, P Vaidya, B Both, C Brew-Graves, J Vaidya

Affiliations

  1. Maastricht University, Maastricht, The Netherlands.
  2. O-Zone HEOR Consultancy, Maastricht, The Netherlands.
  3. Carl-Zeiss Meditec AG, Oberkochen, Germany.
  4. University College London, London, UK.

PMID: 27202288 DOI: 10.1016/j.jval.2014.08.2306

[No abstract available.]

Publication Types